eFFECTOR Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
eFFECTOR Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • eFFECTOR Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -2.16 USD/shares, a 63.8% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -12.6 USD/shares, a 36.5% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -16.4 USD/shares, a 19% decline from 2022.
  • eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -13.8 USD/shares, a 1410% decline from 2021.
  • eFFECTOR Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was 1.05 USD/shares, a 775% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$16 -$3 -19% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$14 -$15 -1410% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $1.05 +$0.93 +775% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $0.12 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.